{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:48:21Z","timestamp":1770403701543,"version":"3.49.0"},"reference-count":47,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15436","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:09:13Z","timestamp":1766149753000},"page":"1-14","source":"Crossref","is-referenced-by-count":0,"title":["Estrogen receptor \u03b1 expression in tumor\u2011infiltrating lymphocytes from patients with endometrial cancer"],"prefix":"10.3892","volume":"31","author":[{"given":"Marcin","family":"Jedryka","sequence":"first","affiliation":[{"name":"Department of Oncology, Wroclaw Medical University, 53\u2011413 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Slawek","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53\u2011114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Kubik","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53\u2011114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Lorek","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53\u2011114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kedzierska","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53\u2011114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Czekanski","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wroclaw Medical University, 53\u2011413 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Matkowski","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wroclaw Medical University, 53\u2011413 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Chelmonska\u2011Soyta","sequence":"additional","affiliation":[{"name":"Laboratory of Reproductive Immunology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53\u2011114 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"key20260206094924_b1-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"e080978","DOI":"10.1136\/bmj-2024-080978","article-title":"Advances in the management of endometrial cancer","volume":"388","author":"Corr","year":"2025","journal-title":"BMJ"},{"key":"key20260206094924_b2-ol-31-2-15436","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260206094924_b3-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"key20260206094924_b4-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"key20260206094924_b5-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"90532","DOI":"10.18632\/oncotarget.20042","article-title":"Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity","volume":"8","author":"Mittica","year":"2017","journal-title":"Oncotarget"},{"key":"key20260206094924_b6-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bjc.1988.44","article-title":"The Dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk","volume":"57","author":"Key","year":"1988","journal-title":"Br J Cancer"},{"key":"key20260206094924_b7-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mce.2015.01.035","article-title":"miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets","volume":"418","author":"Klinge","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"key20260206094924_b8-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12885-017-3601-1","article-title":"Differential expression of estrogen receptor subtypes and variants in ovarian cancer: Effects on cell invasion, proliferation and prognosis","volume":"17","author":"Chan","year":"2017","journal-title":"BMC Cancer"},{"key":"key20260206094924_b9-ol-31-2-15436","first-page":"257","article-title":"Estrogen receptor agonists\/antagonists in breast cancer therapy: A critical review","volume":"71","author":"Jameera Begam","year":"2017","journal-title":"Bio Org Chem"},{"key":"key20260206094924_b10-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"153149","DOI":"10.1016\/j.prp.2020.153149","article-title":"Roles of estrogen receptor \u03b1 and \u03b2 in the regulation of proliferation in endometrial carcinoma","volume":"216","author":"Hu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"key20260206094924_b11-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ygyno.2016.03.006","article-title":"Estrogen receptor-alpha is a predictive biomarker in endometrioid endometrial cancer","volume":"141","author":"Backes","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20260206094924_b12-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-15-1260","article-title":"Infiltrating macrophages induce ER\u03b1 expression through an IL17A-mediated epigenetic mechanism to sensitize endometrial cancer cells to estrogen","volume":"76","author":"Ning","year":"2016","journal-title":"Cancer Res"},{"key":"key20260206094924_b13-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-12-3039","article-title":"Lack of estrogen receptor-\u03b1 is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma","volume":"19","author":"Wik","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20260206094924_b14-ol-31-2-15436","first-page":"3262","article-title":"Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer","volume":"15","author":"Sasaki","year":"2001","journal-title":"Cancer Res"},{"key":"key20260206094924_b15-ol-31-2-15436","first-page":"139","article-title":"Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma","volume":"22","author":"Shiozawa","year":"2002","journal-title":"Anticancer Res"},{"key":"key20260206094924_b16-ol-31-2-15436","first-page":"4026","article-title":"Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5\u2032end of the ER gene","volume":"6","author":"Navari","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20260206094924_b17-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ijgc-2018-000042","article-title":"Clinicopathologic characteristics, tumor infiltrating lymphocytes and programmed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function","volume":"29","author":"Chavez","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"key20260206094924_b18-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ygyno.2009.03.022","article-title":"Presence of Tumor-infiltrating Lymphocytes is an independent prognostic factor in type I and II endometrial cancer","volume":"114","author":"De Jong","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20260206094924_b19-ol-31-2-15436","first-page":"5555","article-title":"Prognostic significance of CD3+ tumorinfiltrating lymphocytes in patients with endometrial carcinoma","volume":"34","author":"\u010cerm\u00e1kov\u00e1","year":"2014","journal-title":"Anticancer Res"},{"key":"key20260206094924_b20-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5468\/ogs.2014.57.4.266","article-title":"Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma","volume":"57","author":"Jung","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"key20260206094924_b21-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"1805764","DOI":"10.1155\/2020\/1805764","article-title":"Tissue infiltrating immune cells as prognostic biomarkers in endometrial cancer: A Meta-analysis","volume":"2020","author":"Guo","year":"2020","journal-title":"Dis Markers"},{"key":"key20260206094924_b22-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1158\/1078-0432.CCR-18-3241","article-title":"Molecular subtype not immune response drives outcomes in endometrial carcinoma","volume":"25","author":"Talhouk","year":"2019","journal-title":"Clin Cancer Res"},{"key":"key20260206094924_b23-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00262-020-02813-3","article-title":"The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: Mutual correlations and prognostic impact depending on molecular alterations","volume":"70","author":"Willvonseder","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"key20260206094924_b24-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-Mutated and Microsatellite-instable endometrial cancers with neoantigen load, number of Tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol"},{"key":"key20260206094924_b25-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.1038\/s41598-017-17102-w","article-title":"Oestrogen Receptor-\u03b1 binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer","volume":"7","author":"Adurthi","year":"2017","journal-title":"Sci Rep"},{"key":"key20260206094924_b26-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1128\/MCB.00118-10","article-title":"Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation","volume":"30","author":"Stender","year":"2010","journal-title":"Mol Cell Biol"},{"key":"key20260206094924_b27-ol-31-2-15436","first-page":"375","article-title":"Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis","volume":"42","author":"Jedryka","year":"2020","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20260206094924_b28-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"154315","DOI":"10.1016\/j.prp.2023.154315","article-title":"Fast and reliable sanger POLE sequencing protocol in FFPE tissues of endometrial cancer","volume":"242","author":"Laczmanska","year":"2023","journal-title":"Pathol Res Pract"},{"key":"key20260206094924_b29-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/ijgo.12612","article-title":"Cancer of the corpus uteri","volume":"143","author":"Amant","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"key20260206094924_b30-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"key20260206094924_b31-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.humpath.2016.05.025","article-title":"CD8 Down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas","volume":"56","author":"Pascual-Garcia","year":"2016","journal-title":"Hum Pathol"},{"key":"key20260206094924_b32-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"640018","DOI":"10.3389\/fonc.2021.640018","article-title":"POLE and mismatch repair status, checkpoint proteins and tumor-infiltrating lymphocytes in combination, and tumor differentiation: Identify endometrial cancers for immunotherapy","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"key":"key20260206094924_b33-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41379-021-00930-7","article-title":"Prognostic implications of tumor-infiltrating T cells in early-stageendometrial cancer","volume":"35","author":"Mendiola","year":"2022","journal-title":"Mod Pathol"},{"key":"key20260206094924_b34-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/0008-5472.CAN-21-4385","article-title":"Beyond T cells: IgA incites immune recognition in endometrial cancer","volume":"82","author":"Osorio","year":"2022","journal-title":"Cancer Res"},{"key":"key20260206094924_b35-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1158\/0008-5472.CAN-21-2376","article-title":"IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer","volume":"82","author":"Mandal","year":"2022","journal-title":"Cancer Res"},{"key":"key20260206094924_b36-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3892\/ol.2023.14117","article-title":"Roles of estrogen receptor \u03b1 in endometrial carcinoma (review)","volume":"26","author":"Ge","year":"2023","journal-title":"Oncol Lett"},{"key":"key20260206094924_b37-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-9-77","article-title":"Distributions of estrogen and progesterone receptor isoforms in endometrial cancer","volume":"9","author":"Kreizman-Shefer","year":"2014","journal-title":"Diagn Pathol"},{"key":"key20260206094924_b38-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"E3255","DOI":"10.1073\/pnas.1509322112","article-title":"Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling","volume":"112","author":"Den Boon","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"key20260206094924_b39-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"e155476","DOI":"10.1172\/JCI155476","article-title":"The role of estrogen receptor signaling in suppressing the immune response to cancer","volume":"131","author":"Rae","year":"2021","journal-title":"J Clin Invest"},{"key":"key20260206094924_b40-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"e151347","DOI":"10.1172\/JCI151347","article-title":"Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma","volume":"131","author":"Chakraborty","year":"2021","journal-title":"J Clin Invest"},{"key":"key20260206094924_b41-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12672-022-00466-5","article-title":"The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H\/MMR-D endometrial carcinomas","volume":"13","author":"Guo","year":"2022","journal-title":"Discov Oncol"},{"key":"key20260206094924_b42-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"975201","DOI":"10.3389\/fonc.2022.975201","article-title":"Importance of the endometrial immune environment in endometrial cancer and associated therapies","volume":"12","author":"van der Woude","year":"2022","journal-title":"Front Oncol"},{"key":"key20260206094924_b43-ol-31-2-15436","first-page":"3269S","article-title":"Review of studies on estrogen biosynthesis in the human","volume":"42","author":"Siiteri","year":"1982","journal-title":"Cancer Res"},{"key":"key20260206094924_b44-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s40064-015-1171-8","article-title":"Serum estrone concentration, estrone sulfate\/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma","volume":"4","author":"Vincze","year":"2015","journal-title":"Springerplus"},{"key":"key20260206094924_b45-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/1055-9965.EPI-16-0821","article-title":"Endometrial cancer risk factors, hormone receptors, and mortality prediction","volume":"26","author":"Busch","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20260206094924_b46-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"e20210042","DOI":"10.1084\/jem.20210042","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function","volume":"219","author":"Dyck","year":"2022","journal-title":"J Exp Med"},{"key":"key20260206094924_b47-ol-31-2-15436","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41366-021-01027-6","article-title":"The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium","volume":"46","author":"Naqvi","year":"2022","journal-title":"Int J Obes"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:49:31Z","timestamp":1770364171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,19]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15436","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}